Boothbay Fund Management’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-78,021
| Closed | -$335K | – | 1597 |
|
|
2025
Q1 | $335K | Hold |
78,021
| – | – | 0.01% | 859 |
|
|
2024
Q4 | $671K | Buy |
+78,021
| New | +$671K | 0.02% | 648 |
|
|
2024
Q1 | – | Sell |
-11,963
| Closed | -$191K | – | 1783 |
|
|
2023
Q4 | $191K | Buy |
+11,963
| New | +$191K | ﹤0.01% | 1184 |
|
|
2023
Q3 | – | Sell |
-1,597
| Closed | -$105K | – | 1899 |
|
|
2023
Q2 | $105K | Hold |
1,597
| – | – | ﹤0.01% | 1385 |
|
|
2023
Q1 | $95.5K | Hold |
1,597
| – | – | ﹤0.01% | 1701 |
|
|
2022
Q4 | $37.2K | Hold |
1,597
| – | – | ﹤0.01% | 1650 |
|
|
2022
Q3 | $53K | Sell |
1,597
-168
| -10% | -$5.58K | ﹤0.01% | 1824 |
|
|
2022
Q2 | $47K | Hold |
1,765
| – | – | ﹤0.01% | 1813 |
|
|
2022
Q1 | $52K | Hold |
1,765
| – | – | ﹤0.01% | 1792 |
|
|
2021
Q4 | $151K | Hold |
1,765
| – | – | ﹤0.01% | 1426 |
|
|
2021
Q3 | $131K | Buy |
+1,765
| New | +$131K | ﹤0.01% | 1491 |
|